Lindsay Ham is currently the Global CNS Franchise Head - Neurodevelopment at Roche, where they have held significant regulatory affairs roles since 2007. They previously served as the Regulatory Affairs Group Leader at Roche and have extensive experience in regulatory affairs across various companies, including Serono and Siegfried. Lindsay earned a PhD in Microbiology from Monash University, completing their studies in 1989.
This person is not in any teams
This person is not in any offices